Press Releases

Global North-America Genetic Testing Market Growth and Share Analysis by Leading Countries, Top Key Players, Regions, Forecast to 2019-2024

North-America Genetic Testing

The Prime objective of “North-America Genetic Testing Market” report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. Important factors supporting growth across various is also provided. Using the industrial figures, the market finds growth figures between the forecast period from 2019 to 2024. In order to present an executive-level model of the market and its future perspectives, the report presents a clear segmentation based on different parameters. The factors that affect these segments are also discussed in detail in the report.

Request For Sample Copy of North-America Genetic Testing Market Report @ https://www.industryresearch.co/enquiry/request-sample/13999526

Top Key Players Are:

  • 23&Me Inc.
  • Abbott Laboratories
  • Ariosa Diagnostics Inc.
  • Cepheid Inc.
  • Illumina Inc.
  • Luminex Corporation
  • Biorad Laboratories Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • F. Hoffmann
  • La Roche Ltd

    North-America Genetic Testing Market Report Covers the Top Regions:

    United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, GCC, South Africa, Brazil, Argentina.

    Scope of North-America Genetic Testing Market:

    As per the scope of this report, a genetic test is performed to identify the presence of a gene with a particular sequence in the genome. The gene can be either identified directly through sequencing or it can be identified indirectly through various methods. These genetic tests are carried out to assess the risk of an individual developing a certain disease.

    Have Any Query, Ask Our Industry Experts @ https://www.industryresearch.co/enquiry/pre-order-enquiry/13999526

    Key Market Trends:

    Predictive and Presymptomatic Testing is the Largest Segment by Type that is Expected to Grow During the Forecast Period

    Predictive and pre-symptomatic testing is utilized for the detection of gene mutations that are related to disorders appearing after birth, frequently in later stages of life. Such tests can be of assistance to individuals having a family member with a genetic disorder, though they are free from any features of the disorder while testing. Predictive testing can aid in the identification of mutations that can increase an individual’s possibilities of developing disorders, as in the case of specific cancers.

    Thus the rising incidences of cancer and growing awareness about the diseases are expected to lead to more such tests, which in turn, is expected to drive the market.

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Purchase North-America Genetic Testing Market Report @ https://www.industryresearch.co/purchase/13999526

    Price of Report: $ 3850 (SUL)

    Detailed TOC of North-America Genetic Testing Market Research Report 2019 – 2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Emphasis on Early Disease Detection and Prevention
    4.2.2 Growing Demand for Personalized Medicine
    4.2.3 Increasing Application of Genetic Testing in Oncology
    4.2.4 Large Demand for Direct-to-customer Genetic Tests
    4.3 Market Restraints
    4.3.1 High Costs of Genetic Testing
    4.3.2 Potentially Adverse Personal or Societal Consequences
    4.3.3 FDA Strictly Regulates Laboratory Developed Tests (LDTs)
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Type
    5.1.1 Carrier Testing
    5.1.2 Diagnostic Testing
    5.1.3 Newborn Screening
    5.1.4 Predictive and Presymptomatic Testing
    5.1.5 Prenatal Testing
    5.1.6 Other Types
    5.2 By Diseases
    5.2.1 Alzheimer’s Diseases
    5.2.2 Cancer
    5.2.3 Cystic Fibrosis
    5.2.4 Sickle Cell Anemia
    5.2.5 Duchenne Muscular Dystrophy
    5.2.6 Thalassemias
    5.2.7 Huntington’s Disease
    5.2.8 Special Diseases
    5.2.9 Other Diseases
    5.3 By Technology
    5.3.1 Cytogenetic Testing
    5.3.2 Biochemical Testing
    5.3.3 Molecular Testing
    5.4 Geography
    5.4.1 North America
    5.4.1.1 United States
    5.4.1.2 Canada
    5.4.1.3 Mexico

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 23&Me Inc.
    6.1.2 Abbott Laboratories
    6.1.3 Ariosa Diagnostics Inc.
    6.1.4 Cepheid Inc.
    6.1.5 Illumina Inc.
    6.1.6 Luminex Corporation
    6.1.7 Biorad Laboratories Inc.
    6.1.8 PerkinElmer Inc.
    6.1.9 Quest Diagnostics Incorporated
    6.1.10 F. Hoffmann-La Roche Ltd

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Smart Watch Market 2019 Global Industry Size, Demand, Growth Analysis, Share, Revenue and Forecast 2024